调节T细胞反应以增强放射治疗的影响
Matías Fernández Muñoz1, Mai K Bishr1, Ben O'Leary2
1The Institute of Cancer Research, Radiotherapy and Imaging Division, Translational Immunotherapy Group.
Cancer journal (Sudbury, Mass.)
|August 6, 2025
概括
放射治疗对癌症免疫有双重影响,可能增强或抑制抗瘤反应. 优化其与免疫治疗的结合需要理解和平衡这些免疫调节效应,特别是对T细胞.
科学领域:
- 在瘤学瘤学.
- 免疫学 免疫学 免疫学
- 辐射瘤学 辐射瘤学
背景情况:
- 在历史上,放射治疗一直专注于直接杀死瘤细胞.
- 免疫疗法已经成为一种主要的癌症治疗方式.
- 放射治疗对免疫系统的影响是复杂的,具有有益和有害的影响.
研究的目的:
- 审查目前对放射治疗免疫调节效应的理解.
- 探索放射疗法和免疫疗法在癌症治疗中的结合.
- 在联合治疗策略中专注于优化T细胞反应.
主要方法:
- 对放射治疗和免疫治疗的临床前和临床研究的审查.
- 分析辐射疗法的免疫效应背后的机制.
- 专注于T细胞的反应及其调节.
主要成果:
- 放射治疗对免疫系统具有"双刃剑"的作用.
- 它可以增强抗瘤免疫力,但也会导致免疫抑制.
- 细胞毒性T淋巴细胞 (CTL) 是免疫治疗的关键点,并且受到放射治疗的影响.
结论:
- 优化联合放射疗法和免疫疗法至关重要.
- 策略应该利用促进免疫效应,同时减轻免疫抑制.
- 需要对潜在机制进行进一步的研究,以完善T细胞调节.
更多相关视频
12:55Generation of CAR T Cells for Adoptive Therapy in the Context of Glioblastoma Standard of Care
Published on: February 16, 2015
21.5K
07:20Ex vivo Expansion of Tumor-reactive T Cells by Means of Bryostatin 1/Ionomycin and the Common Gamma Chain Cytokines Formulation
Published on: January 14, 2011
14.8K
相关概念视频
Tumor Immunotherapy
660
Immunotherapy is a treatment that boosts or manipulates the immune system to fight diseases, including cancer. For instance, by stimulating an immune response through vaccinations against viruses that cause cancers, like hepatitis B virus and human papillomavirus, these diseases can be prevented. Nonetheless, some cancer cells can avoid the immune system due to their rapid mutation and division. The immune response to many cancers involves three phases: elimination, equilibrium, and escape.
660
T Cell Activation and Clonal Selection
4.7K
T cells are integral to our adaptive immune system, recognizing and effectively responding to foreign antigens. T cell activation and clonal selection are pivotal in orchestrating this immune response. This article elucidates these mechanisms, detailing the roles of cluster of differentiation (CD) markers, major histocompatibility complex (MHC) molecules, costimulatory signals, and the process of clonal selection.
Naive T cells that have not yet encountered an antigen express two primary CD...
Naive T cells that have not yet encountered an antigen express two primary CD...
4.7K
Targeted Cancer Therapies
7.8K
The targeted cancer therapies, also known as “molecular targeted therapies,” take advantage of the molecular and genetic differences between the cancer cells and the normal cells. It needs a thorough understanding of the cancer cells to develop drugs that can target specific molecular aspects that drive the growth, progression, and spread of cancer cells without affecting the growth and survival of other normal cells in the body.
There are several types of targeted therapies against...
There are several types of targeted therapies against...
7.8K
Cell-mediated Immune Responses
72.7K
Overview
72.7K
The Tumor Microenvironment
6.8K
Every normal cell or tissue is embedded in a complex local environment called stroma, consisting of different cell types, a basal membrane, and blood vessels. As normal cells mutate and develop into cancer cells, their local environment also changes to allow cancer progression. The tumor microenvironment (TME) consists of a complex cellular matrix of stromal cells and the developing tumor. The cross-talk between cancer cells and surrounding stromal cells is critical to disrupt normal tissue...
6.8K
Cytotoxic T Cells-mediated Immune Response
2.0K
Cytotoxic T cells are a vital component of the immune system. They have the remarkable ability to identify and target antigens on infected or abnormal cells. These antigens often originate from intracellular pathogens such as viruses or abnormal proteins cancer cells produce.
Immunological surveillance is the ability of immune cells to monitor and eliminate infected cells with intracellular pathogens, neoplastically transformed cells, and cells with non-self antigens. Cytotoxic T cells and NK...
Immunological surveillance is the ability of immune cells to monitor and eliminate infected cells with intracellular pathogens, neoplastically transformed cells, and cells with non-self antigens. Cytotoxic T cells and NK...
2.0K
